Australia markets closed

GeneDx Holdings Corp. (WGS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
22.39-1.63 (-6.79%)
At close: 04:00PM EDT
22.39 0.00 (0.00%)
After hours: 05:13PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
231,145
202,566
234,694
212,195
179,322
Cost of revenue
244,375
112,560
261,444
228,797
175,296
Gross profit
-13,230
90,006
-26,750
-16,602
4,026
Operating expenses
Research development
84,083
58,266
86,203
105,162
72,700
Selling general and administrative
354,398
194,711
338,242
318,726
163,925
Total operating expenses
445,320
260,200
430,757
429,547
246,020
Operating income or loss
-458,550
-170,194
-457,507
-446,149
-241,994
Interest expense
3,111
-
3,207
2,835
2,474
Total other income/expenses net
130,688
-7,613
-139,859
203,515
2,622
Income before tax
-329,546
-176,693
-598,032
-245,390
-241,340
Income tax expense
-49,142
-926
-49,052
0
0
Income from continuing operations
-280,404
-175,767
-548,980
-245,390
-241,340
Net income
-280,404
-175,767
-548,980
-245,390
-241,340
Net income available to common shareholders
-280,404
-175,767
-548,980
-245,390
-241,340
Basic EPS
-35.44
-7.23
-53.63
-74.91
-33.16
Diluted EPS
-35.44
-7.23
-53.63
-74.91
-33.16
Basic average shares
20,764
24,312
10,237
3,275
7,278
Diluted average shares
20,764
24,312
10,237
3,275
7,278